# Changes in QoL and Symptoms in Patients With Polycythemia Vera Receiving Ruxo in a Routine Clinical Practice

> **NCT05566535** · — · UNKNOWN · sponsor: **Multinational Center for Quality of Life Research, Russia** · enrollment: 32 (estimated)

## Conditions studied

- Polycythemia Vera

## Interventions

- **DRUG:** Ruxolitinib

## Key facts

- **NCT ID:** NCT05566535
- **Lead sponsor:** Multinational Center for Quality of Life Research, Russia
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-10-01
- **Primary completion:** 2024-05-01
- **Final completion:** 2024-08-01
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2022-10-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05566535

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05566535, "Changes in QoL and Symptoms in Patients With Polycythemia Vera Receiving Ruxo in a Routine Clinical Practice". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05566535. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*